Comparison of clinical guidelines for the diagnosis and treatment of chronic heart failure of ČKS and ESC 2012

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10172791" target="_blank" >RIV/00216208:11110/13:10172791 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/13:00070480 RIV/00064165:_____/13:10172791

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S0010865013000404" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0010865013000404</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2013.03.011" target="_blank" >10.1016/j.crvasa.2013.03.011</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Comparison of clinical guidelines for the diagnosis and treatment of chronic heart failure of ČKS and ESC 2012

Popis výsledku v původním jazyce

In 2012, the Czech and European clinical guidelines for diagnosis and treatment of heart failure have been issued. The main difference between them is that the European guidelines include both acute and chronic heart failure while our national guidelinescontain only chronic heart failure. They differ even in the definition of heart failure; the European guidelines do not include natriuretic peptides among the diagnostic criteria and response to treatment as an auxiliary criterion in cases of unclear diagnosis. Regarding signs and symptoms of heart failure, both guidelines are similar in this part, they only differ in their categorization. In diagnosis section, the guidelines vary in certain echocardiographic parameters, particularly of diastolic dysfunction. Cut-off points for natriuretic peptides in chronic heart failure are entirely new in the European guidelines. For patients presenting in a non-acute way, the optimum cut-off point is 125 pg/mL for NT-proBNP and 35 pg/mL for BNP. D

Název v anglickém jazyce

Comparison of clinical guidelines for the diagnosis and treatment of chronic heart failure of ČKS and ESC 2012

Popis výsledku anglicky

In 2012, the Czech and European clinical guidelines for diagnosis and treatment of heart failure have been issued. The main difference between them is that the European guidelines include both acute and chronic heart failure while our national guidelinescontain only chronic heart failure. They differ even in the definition of heart failure; the European guidelines do not include natriuretic peptides among the diagnostic criteria and response to treatment as an auxiliary criterion in cases of unclear diagnosis. Regarding signs and symptoms of heart failure, both guidelines are similar in this part, they only differ in their categorization. In diagnosis section, the guidelines vary in certain echocardiographic parameters, particularly of diastolic dysfunction. Cut-off points for natriuretic peptides in chronic heart failure are entirely new in the European guidelines. For patients presenting in a non-acute way, the optimum cut-off point is 125 pg/mL for NT-proBNP and 35 pg/mL for BNP. D

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

55

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

8

Strana od-do

"e301"-"e308"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—